←
Matthew Halma5,928 posts
Matthew Halma avatar

Matthew Halma

@MatthewHalma

Biophysicist | #Postviral syndromes, #longCOVID, #PACVS | Open Source Medicine Foundation | opensourcemed.info

◷ Joined October 2022▧ 337 Photos and videos
Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 14

1/ Long COVID and post-acute COVID-19 vaccination syndrome (PACVS) share the same core picture: fatigue, brain fog, post-exertional malaise, dysautonomia. No routine clinical test separates them. What does the biomarker research show? 🧵 Fig: Purpura et al., Clin Infect Dis 2026 (CC BY-NC-ND 4.0)

Post attachment
Stray avatar
⟳ Matthew Halma retweeted
Stray@K9FCR·17h

わかったような帯グラフがありますけど、実際には何にもわかってない状態で、世界中で拡大接種を決行したんですな。 血中単球が持続的にスパイクタンパクを保持するのも後からわかったんだし。

8/ Spike persistence. Patterson et al. (HV&I 2025) studied 50 PCVS patients with no evidence of prior infection. In a subset tested by flow cytometry (n=12), they reported S1 in CD16+ monocytes up to 245 days after vaccination, plus raised sCD40L, CCL5, IL-6 and IL-8. The same group had earlier reported S1 persistence after infection. Fig: Patterson 2025 Fig 4 (CC BY-NC 4.0)

Post attachment
Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 17

8:54

I've been reading published studies of neurotransmitter differences in long COVID versus comparison groups. The most consistent finding is reduced GABA-B inhibition on TMS. Two 2026 papers now point to catecholamines, while peripheral serotonin is still contested. #LongCOVID

Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 16

I found no neurotransmitter study in PACVS — a gap, not evidence of no difference. Next: independent replication of the 2026 PET and CSF findings, and serotonin assays that handle platelets and SSRI use carefully. Observational only. #LongCOVID #PACVS #LakshmiPriya

Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 16

Aregawi et al. 2026 (NIH) found lower CSF norepinephrine-pathway activity in PASC than in volunteers (−9.62 pmol/mL, 95% CI −17.9 to −1.4, P=0.015), and lower still with PEM (−18.3, P=0.0018). The dopamine pathway did not differ. Single-centre. doi.org/10.1093/braincomms/f…

Post attachment
Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 16

What stood out to me in Liu et al. 2026 is the PET finding. Striatal VMAT2, a dopamine-terminal marker, was lower than in controls (BPND 1.60 [SD 0.30] vs 1.91 [0.21]; 24 vs 24; P=0.000038). Apathy/depressive phenotype. Single-centre, unreplicated. doi.org/10.1016/j.ebiom.2026…

Post attachment
Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 16

The most replicated physiology finding is reduced LICI, a GABA-B marker, on motor-cortex TMS. Versace 2021 found it in 12 post-acute pneumonia survivors versus 10 controls, 9–13 weeks after onset, along with reduced SICI. doi.org/10.1016/j.clinph.202…

Matthew Halma avatar
Matthew Halma@MatthewHalma·Nov 16

I've been reading published studies of neurotransmitter differences in long COVID versus comparison groups. The most consistent finding is reduced GABA-B inhibition on TMS. Two 2026 papers now point to catecholamines, while peripheral serotonin is still contested. #LongCOVID

Kevin Rose avatar
⟳ Matthew Halma retweeted
Kevin Rose@kevinrose·Nov 16

DocuSign wants $8,100/yr from a 15-person team just to sign PDFs. So I built SignuDoc: open source, one-click deploy to your own @vercel account, $0 per seat. White-label branding, full audit trails, tamper-evident seals and your documents never leave your cloud.